Download PDF
1
/
Pages
Previous article
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn¿s Disease and Ulcerative Colitis
Francisco Rodríguez-Moranta; Federico Argüelles-Arias; Joaquín Hinojosa del Val; Marisa Iborra Colomino; M. Dolores Martín-Arranz; Luis Menchén Viso; Fernando Muñoz Núñez; Elena Ricart Gómez; José Germán Sánchez-Hernández; Teresa Valdés-Delgado; Jordi Guardiola Capón; Manuel Barreiro-de Acosta; Míriam Mañosa Ciria; Yamile Zabana Abdo; Ana Gutiérrez Casbas;
Gastroenterol Hepatol. 2024;47:522-52
Incidence, and natural history of inflammatory bowel disease in Castilla y León:Prospective and multicenter epidemiological study
Rosa María Sáiz-Chumillas; Jesús Barrio; Luis Fernández-Salazar; Lara Arias; Mónica Sierra Ausín; Concepción Piñero; Ana Fuentes Coronel; Laura Mata; Mónica Vásquez; Ana Carbajo; Noelia Alcaide; Noelia Cano; Aejandro Nuñez; Paola Fradejas; Mercedes Ibáñez; Luis Hernández; Beatriz Sicilia;
Gastroenterol Hepatol. 2023;46:102-8
Relevance and needs of irritable bowel syndrome (IBS): Comparison with inflammatory bowel disease (IBD). (Please, if you are not interested in IBS, read it.)
Fermín Mearin; Miquel Sans; Agustín Balboa;
Gastroenterol Hepatol. 2022;45:789-98